表紙
市場調査レポート

米国のPOC(ポイントオブケア)診断検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境

US POC/Point-of-Care Diagnostic Testing Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

発行 Venture Planning Group 商品コード 304671
出版日 ページ情報 英文 1172 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。

Local License: 同一事業所内

Back to Top
米国のPOC(ポイントオブケア)診断検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境 US POC/Point-of-Care Diagnostic Testing Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape
出版日: ページ情報: 英文 1172 Pages
概要

当レポートでは、米国におけるポイントオブケア(POC)向け診断検査技術の市場の現状・将来展望について分析し、関連技術および市場(検査試薬・試薬など)の最新状況や、部門別の市場規模および成長率(今後5年間分)、今後の市場機会、規制環境、競争構造、主要企業のプロファイルなどを調査して、その結果を概略以下の構成でお届けします。

イントロダクション

エグゼクティブ・サマリー

検査の分散化の合理的根拠

世界の市場・技術の概況

  • 主なルーチン化学検査(全30種)
  • 感染症検査(全33種類)
  • 腫瘍マーカー(全5種類)
  • 主なルーチン・特殊血液検査(CBC分析)
  • 内分泌機能検査(全13種類)
  • 治療薬物モニタリング検査(TDM)(全11種類)
  • 血液凝固検査(全13種類)
  • 免疫タンパク質検査(2種類)
  • 薬物乱用検査(全12種類)
  • 検査装置
    • 化学分析装置
    • 血液分析装置
    • 血液凝固分析装置
  • 現在・将来の技術
    • モノクローナル抗体
    • 免疫検定
    • ドライケミストリー
    • バイオセンサー
    • IT・自動化
    • 分子診断

世界の事業環境

米国市場

  • 市場概要
    • 事業環境
    • 市場構造
  • 個別化検査
    • 血糖値モニタリング
    • 妊娠検査
    • 潜血検査
    • 市場規模と成長率
  • 開業医/グループ検診
    • 市場概要
    • 市場構造
    • 検査件数・売上高の予測値
  • 補助的医療施設
    • イントロダクション
    • 救急部門
    • 手術・回復室
    • ICU(集中治療室)/CCU(冠疾患集中治療室)
  • がんクリニック
  • 外来治療センター
  • 手術センター
  • 介護施設(ナーシングホーム)
  • 産院
  • 主要サプライヤーの装置設置台数・設置ベース・試薬販売額・市場シェア

主な製品開発機会

  • ルーチン・特殊化学検査
  • 微生物/感染症検査
  • 血液検査・フローサイトメトリー
  • 血液凝固検査

分散型検査製品の設計基準

代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業評価(全49社)

  • Abbott
  • ADI/America Diagnostica
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Biosite/Inverness/Alere
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • 栄研化学
  • EKF Diagnostics
  • 富士レビオ/Innogenetics
  • Grifols
  • Helena Laboratories
  • Hologic/Gen-Probe
  • 堀場製作所
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech
  • 協和メデックス
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • 日本光電
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • シスメックス
  • タカラバイオ
  • ThermoFisher/Life Technologies
  • 東ソー
  • 和光純薬工業
  • Zycare/Alere

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPPOC19988

VPGMarketResearch’s new report provides comprehensive analysis of the ten POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the ten POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

- Home/Personal Testing Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

   and by test category:

- Routine and Special Chemistry Microbiology/Infectious Diseases Hematology Flow Cytometry Coagulation Immunoproteins Drugs of Abuse TDM Endocrine Function Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Tests and Instrumentation

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers market by Abaxis, Abbott, Alfa Wasserman, Awareness Technologies, Beckman Coulter/Danaher, Becton Dickinson, Behnk Elektronik, Biocode, Bio/Data, bioMerieux, Cardiovascular Diagnostics, Carolina Chemistries, Diagnostica Stago, Diesse Ves Matic, Drew-Scientific, Helena Laboratories, Horiba, Instrumentation Laboratory, Inverness, ITC Hemochron, Medica, Menarini, Nihon Kohden, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Sysmex, Teco Medical Instruments, Trinity Biotech, and other suppliers.

Routine Clinical Chemistry Tests

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine, GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Infectious Disease Tests

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculois, Vibrio, West Nile, Yersenia.

Tumor Markers

ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Routine and Special Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils and others.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Endocrine Function Tests

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests

Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Immunoprotein Tests

C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - ADI/American Diagnostica    - Agilent Technologies    - Alere/Biosite/Inverness    - Axis-Shield    - Beckman Coulter/Danaher    - Becton Dickinson    - Bio/Data    - Biomerieux    - Bio-Rad    - Cepheid    - Chrono-Log    - Corgenix/Orgentec    - Decode Genetics    - Diadexus    - Diagnocure    - Diagnostica Stago/Trinity Biotech    - Diamedix/Erba    - Diasorin    - Eiken Chemical    - EKF Diagnostics    - Fujirebio    - Grifols    - Helena Laboratories    - Hologic/Gen-Probe    - Horiba    - Instrumentation Laboratory    - International Technidyne/Nexus DX    - Kreatech/Leica    - Kyowa Medex    - Lonza    - Mackay Life Sciences    - Matritech    - Nihon Kohden    - Ortho-Clinical Diagnostics    - Polartechnics    - Polymedco    - Qiagen    - Roche    - SDIX    - Sequenom    - Siemens    - Sienco    - Sysmex    - Takara Bio    - Thermo Fisher    - Tosoh    - Wako    - Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 1,172 pages and 256 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests

  • 1. Albumin
  • 2. Alkaline Phosphatase
  • 3. ALT/SGPT
  • 4. Ammonia
  • 5. Amylase
  • 6. AST/SGOT
  • 7. Bilirubin
  • 8. Blood Gases
  • 9. Blood Urea Nitrogen (BUN)
  • 10. Calcium
  • 11. Cholesterol
  • 12. Cholinesterase
  • 13. Creatinine
  • 14. Electrolytes
    • a. Carbon Dioxide/Bicarbonate
    • b. Chloride
    • c. Potassium
    • d. Sodium
  • 15. Ferritin
  • 16. Follate/Folic Acid
  • 17. Fructosamine
  • 18. Gamma-Glutamyl Transpeptidase (GGT)
  • 19. Glucose
  • 20. High Density Lipoprotein (HDL)
  • 21. Iron
  • 22. Lactate Dehydrogenase (LDH)
  • 23. Magnesium
  • 24. Phosphorus
  • 25. Protein
  • 26. Triglycerides
  • 27. Troponin
  • 28. Uric Acid
  • 29. Urinalysis
  • 30. Vitamin B12

Infectious Disease Tests

  • 1. AIDS
  • 2. Adenovirus
  • 3. Campylobacter
  • 4. Candida
  • 5. Chlamydia
  • 6. Clostridium Difficile
  • 7. Cytomegalovirus
  • 8. Enteroviruses
  • 9. Epstein-Barr Virus
  • 10. Gonorrhea
  • 11. Helicobacter Pylori
  • 12. Hepatitis
    • a. Hepatitis A
    • b. Hepatitis B
    • c. Hepatitis C
    • d. Hepatitis D
  • 13. Herpes Simplex Virus
  • 14. Human Herpes Virus-6 (HHV-6)
  • 15. Influenza Viruses
  • 16. Legionella
  • 17. Lyme Disease
  • 18. Measles (Rubeola)
  • 19. Meningitis
  • 20. Mononucleosis
  • 21. Mumps
  • 22. Mycoplasma
  • 23. Papillomaviruses
  • 24. Pneumonia
  • 25. Respiratory Syncytial Virus (RSV)
  • 26. Rheumatoid Arthritis
  • 27. Rotavirus (Reovirus)
  • 28. Rubella (German Measles)
  • 29. Salmonellosis
  • 30. Shigellosis
  • 31. Staphylococcus Aureus
  • 32. Streptococci
  • 33. Syphilis

Tumor Markers

  • 1. Alpha-Fetoprotein (AFP)
  • 2. Carcinoembrionic Antigen (CEA)
  • 3. Occult Blood
  • 4. Prostatic Acid Phosphatase (PAP)
  • 5. Prostate-Specific Antigen (PSA)

Major Routine and Special Hematology Tests

  • 1. CBC Analysis
    • a. Hemoglobin Concentration
    • b. Hematocrit Determination
    • c. Red Blood Cell Count
    • d. Platelets

Endocrine Function Tests

  • 1. Cortisol
  • 2. Follicle-Stimulating Hormone (FSH)
  • 3. Gastrin
  • 4. Human Chorionic Gonadotropin (HCG)
  • 5. LH
  • 6. Prolactin
  • 7. T3
  • 8. T3 Uptake
  • 9. Free T3
  • 10. Thyroxine (T4)
  • 11. Free T4
  • 12. TBG
  • 13. TSH

Therapeutic Drug Monitoring (TDM)

  • 1. Overview
  • 2. Carbamazepine
  • 3. Digoxin
  • 4. Gentamicin
  • 5. Lidocaine
  • 6. Lithium
  • 7. Phenytoin/Dilantin
  • 8. Procainamide
  • 9. Quinidine
  • 10. Theophylline
  • 11. Valproic Acid

Coagulation Tests

  • 1. Introduction
  • 2. Activated Partial Thromboplastin Time (APTT)
  • 3. Alpha-2 Antiplasmin
  • 4. Antithrombin III
  • 5. Bleeding Time
  • 6. D-Dimer
  • 7. Factor VIII
  • 8. Fibrin Degradation Products
  • 9. Fibrinogen
  • 10. Heparin
  • 11. Proteins C and S
  • 12. Prothrombin Time (PT)
  • 13. Thrombin Time

Immunoprotein Tests

  • 1. CRP
  • 2. Immunoglobulins

Drugs of Abuse

  • 1. Overview
  • 2. Test Methodologies
  • 3. Amphetamines
  • 4. Barbiturates
  • 5. Benzodiazepines
  • 6. Cannabinoids/Marijuana
  • 7. Cocaine
  • 8. Lysergic Acid Diethylamide (LSD)
  • 9. Methadone
  • 10. Methaqualone
  • 11. Opiates
  • 12. Phencyclidine

Instrumentation

  • 1. Chemistry Analyzers Manufactured by:
    • Abaxis
    • Abbott
    • Alfa Wassermann
    • Awareness Technologies
    • Beckman Coulter/Danaher
    • bioMeriuex
    • Carolina Chemistries
    • Horiba
    • Inverness
    • Medica
    • Nova Biomedical
    • Ortho-Clinical Diagnostics
    • Polimedco
    • Randox
    • Roche
  • 2. Hematology Analyzers Manufactured by:
    • Abbott
    • Becton Dickinson
    • Beckman Coulter/Danaher
    • Biocode
    • Drew-Scientific
    • Diesse Ves Matic
    • Horiba
    • Menarini
    • Nihon Kohden
    • Polymedco
    • Sysmex
  • 3. Coagulation Analyzers Manufactured by:
    • Behnk Elektronik
    • Bio/Data
    • Cardiovascular Diagnostics
    • Diagnostica Stago
    • Helena Laboratories
    • Instrumentation Laboratory
    • ITC Hemochron
    • Roche
    • Siemens
    • Sysmex
    • Teco Medical Instruments
    • Trinity Biotech

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

Worldwide Business Environment

U.S.A.

A. Market Overview

  • 1. Business Environment
    • a. Health Care Expenditures
    • b. Cost Consciousness
    • c. Reimbursement
    • d. Industry Consolidation
    • e. Managed Care
      • PPO
      • HMO
    • f. Hospitals
    • g. Admissions
    • h. Length of Stay
    • i. Industry Diversification
    • j. Physician Demographics
    • k. Aging Population
      • More Chronic Illness
      • Disease Incidence
      • Susceptibility to latrogenesis
      • Multiple Illnesses Cases
  • l. Laboratory Regulations
  • 2. Market Structure
    • a. Hospitals
    • b. Commercial/Private Laboratories

B. Personal Testing

  • 1. Glucose Monitoring
    • Market and Technology Overview
    • Invasive Testing
    • Non-Invasive Testing
    • Genetic Testing
  • 2. Pregnancy Tests
  • 3. Occult Blood Tests
  • 4. Market Size and Growth

C. Physician Offices/Group Practices

  • 1. Market Summary
  • 2. Market Structure
  • 3. Test Volume and Sales Forecasts

D. Ancillary Hospital Locations

  • 1. Introduction
    • a. Emergency Departments
    • b. Operating Suites
    • c. Intensive Care Units
  • 2. Emergency Departments
    • a. Market Summary
    • b. Test volume and Sales Forecasts
  • 3. Operating and Recovery Suites
    • a. Market Summary
    • b. Test Volume and Sales Forecasts
  • 4. ICUs/CCUs
    • a. Market Summary
    • b. Test Volume and Sales Forecasts

E. Cancer Clinics

  • 1. Introduction
  • 2. Market Summary
  • 3. Test Volume and Sales Forecasts

F. Ambulatory Care Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

G. Surgery Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

H. Nursing Homes

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

I. Birth Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

J. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Major Product Development Opportunities

  • A. Routine and Special Chemistry
  • B. Microbiology/Infectious Diseases
  • C. Hematology and Flow Cytometry
  • D. Coagulation

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • ADI/America Diagnostica
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Biosite/Inverness/Alere
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio/Innogenetics
  • Grifols
  • Helena Laboratories
  • Hologic/Gen-Probe
  • Horiba
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech
  • Kyowa Medex
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • Sysmex
  • Takara Bio
  • ThermoFisher/Life Technologies
  • Tosoh
  • Wako
  • Zycare/Alere

List of Tables

  • Executive Summary Table I: All Decentralized Testing Markets, Diagnostics Sales Forecasts by Market Segment
  • Executive Summary Table II: All Decentralized Testing Markets, Reagent Sales Forecasts by Market Segment
  • Executive Summary Table III: All Decentralized Testing Markets, Instrument Sales Forecasts by Market Segment
  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin/Dilantin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-Dimer Tests
  • Major Companies Developing or Marketing Factor Assays Tests
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing CRP Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • U.S.A., Personal Testing Total Diagnostic Market Forecast
  • U.S.A., Physician Offices/Group Practices Total Diagnostic Sales Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Reagent Sales Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Instrument Sales Forecast by Market Segment
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Physician Offices Laboratories Major Infectious Disease Test Volume Forecast
  • U.S.A., Physician Offices/Group Practice Microbiology Test Volume Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Routine Hematology Test Volume Forecast
  • U.S.A., Physician Offices Laboratories Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Coagulation Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Immunoprotien Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Microbiology/Infectious Disease Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Tumor Markers Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Immunoprotein Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Physician Offices Laboratories Major Infectious Disease Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Microbiology Reagent Market Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Consumables Market Forecast
  • U.S.A., Physician Offices/Group Practices TDM Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Endocrine Function Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Coagulation Reagent Market Forecast
  • U.S.A., Physician Offices/Group Practices Immunoprotein Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Hospital Emergency Departments Reagent Sales Forecast by Market Segment
  • U.S.A., Hospital Emergency Departments Instrument Sales Forecast by Market Segment
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Routine Hematology Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Coagulation Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Selected Infectious Disease Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Hospital Emergency Departments Hematology Reagent Market Forecast
  • U.S.A., Hospital Emergency Departments Coagulation Reagent Market Forecast
  • U.S.A., Hospital Emergency Departments Selected Infectious Disease Reagent Market Forecast by Test
  • U.S.A., Hospital Operating and Recovery Suites Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Hospital Operating and Recovery Suites Reagent Sales Forecast by Market Segment
  • U.S.A., Hospital Operating and Recovery Suites Instrument Sales Forecast By Market Segment
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent Market Forecast
  • U.S.A., Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Instrument Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Routine Hematology Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Reagent Market Forecast
  • U.S.A., Cancer Clinics Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Cancer Clinics Reagent Sales Forecast by Market Segment
  • U.S.A., Cancer Clinics Instrument Sales Forecast by Market Segment
  • U.S.A., Cancer Clinics Major Tumor Markers Test Volume Forecast
  • U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Cancer Clinics Routine Hematology/Flow Cytometry Test Volume Forecast
  • U.S.A., Cancer Clinics Endocrine Function Test Volume Forecast
  • U.S.A., Cancer Clinics Coagulation Test Volume Forecast
  • U.S.A., Cancer Clinics Major Tumor Marker Sales Forecast by Test
  • U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Cancer Clinics Hematology And Flow Cytometry Reagent Market Forecast
  • U.S.A., Cancer Clinics Endocrine Function Reagent Market Forecast
  • U.S.A., Cancer Clinics Coagulation Reagent Market Forecast
  • U.S.A., Ambulatory Care Centers Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Ambulatory Care Centers Reagent Sales Forecast by Market Segment
  • U.S.A., Ambulatory Care Centers Instrument Sales Forecast by Market Segment
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Coagulation Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
  • U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent Market Forecast by Test
  • U.S.A., Ambulatory Care Centers Coagulation Reagent Market Forecast
  • U.S.A., Surgery Centers Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Surgery Centers Reagent Sales Forecast by Market Segment
  • U.S.A., Surgery Centers Instrument Sales Forecast by Market Segment
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Surgery Centers Routine Hematology Test Volume Forecast
  • U.S.A., Surgery Centers Coagulation Test Volume Forecast
  • U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., Surgery Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Surgery Centers Hematology Consumable Market Forecast
  • U.S.A., Surgery Centers Coagulation Reagent Market Forecast
  • U.S.A., Nursing Homes Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Nursing Homes Reagent Sales Forecast by Market Segment
  • U.S.A., Nursing Homes Instrument Sales Forecast by Market Segment
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Nursing Homes Coagulation Test Volume Forecast
  • U.S.A., Nursing Homes Routine Hematology Test Volume Forecast
  • U.S.A., Nursing Homes Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Nursing Homes Coagulation Reagent Market Forecast
  • U.S.A., Nursing Homes Hematology Reagent Market Forecast
  • U.S.A., Birth Centers Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Birth Centers Reagent Sales Forecast by Market Segment
  • U.S.A., Birth Centers Instrument Sales Forecast by Market Segment
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Birth Centers Profiles, Panels and Individual Tests
  • U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., Birth Centers Coagulation Test Volume Forecast
  • U.S.A., Birth Centers Routine Hematology Test Volume Forecast
  • U.S.A., Birth Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Birth Centers Microbiology and Serology Testing Market Forecast
  • U.S.A., Birth Centers Hematology Reagent Market Forecast
  • U.S.A., Birth Centers Coagulation Reagent Market Forecast
  • U.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
  • U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., AFP Testing Market By Major Suppliers
  • U.S.A., CA 15-3/27-29 Testing Market by Major Suppliers
  • U.S.A., CA 19-9 Testing Market by Major Suppliers
  • U.S.A., CEA Testing Market by Major Suppliers
  • U.S.A., PAP Testing Market by Major Suppliers
  • U.S.A., PSA Testing Market by Major Suppliers
  • U.S.A., Hematology Analyzers Estimated Placements and Installed Base
  • U.S.A., Flow Cytometers Estimated Placements and Installed Base
  • U.S.A., Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hematology Instrument Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hematology Consumable Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Instruments Market Estimated Market Shares of Major Suppliers
  • U.S.A., Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares of Major Suppliers
Back to Top